banda transcan 2 2016ul


 "Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy"  

is open for submission

Please visit the TRANSCAN-3 website at

Other news (outside TRANSCAN):

The Digital Institute for Cancer Outcomes Research (DIGICORE), a 30-strong network of cancer centres established as an EU European Economic Interest Group, is delighted to announce an innovative new training programme for early career researchers in oncology.

IDEAL4RWE is a new training program to equip early-career researchers (<45 years old) with the technical and leadership skills to build collaborative teams for oncology RWE research. 

Please register for an introductory webinar on the 19th April 2022 (

Brochure for more details:

TRANSCAN-3  Joint Transnational Call 2021, co-funded by the European Commission
"Next generation cancer immunotherapy: targeting the tumour microenvironment"
is closed

International Networking Event (virtual)

was held on 22 April 2021 hrs 9:00 CET

focussed on the  co-funded Joint Transnational Call for proposals, JTC2021, on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 

event organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3

 A TRANSCAN-2 brochure, highlighting key achievements, is available for download.

The 3rd and final TRANSCAN-2 symposium on Tumour Heterogeneity was held in Milan on October 24th, 2019

The symposium included talks from the funded consortia of JTC2014 co-funded by the EU, an exciting discussion on the impact and added value of transnational collaborations on cancer research and a poster prize competition for young scientists.
The event was hosted by Regione Lombardia, Italy, with the collaboration of Fondazione Regionale per la Ricerca Biomedica

Abstract book
For further information please contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

JTC 2017 on: Translational research on rare cancers

12 projects selected for funding, visit the page

JTC 2016 on: Minimally and non-invasive methods for early detection and/or progression of cancer.

14 projects selected for funding

JTC 2015 on: Immunology and immunotherapy of cancer: strengthening the translational aspects.

7 projects selected for funding

JTC 2014 on: Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy.

16 projects selected for funding


 TRANSCAN-3 news:
twitter logoinkedin social media logo
 The new ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download



The TRANSCAN-3 newsletters are published at:

SUBSCRIBE to the newsletters
You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter

All the TRANSCAN-2 newsletters:

Newsletter 10, Sept.2020
Newsletter 9, Dec.2019

Newsletter 8, May 2019
Newsletter 7, Oct.2018
Newsletter 6, June 2108
Newsletter 5, March 2018
Newsletter 4, Dec. 2017
Newsletter 3, Sept. 2017
Newsletter 2, April 2017
Newsletter 1, Dec. 2016

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 9 guests and no members online